Trial Profile

A Non Interventional, Retrospective Study on Real World Usage and Treatment Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to the SIADH.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Dec 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tolvaptan (Primary)
Indications Hyponatraemia
Focus Therapeutic Use
Acronyms SAMPLE
Sponsors Otsuka Pharmaceutical

Most Recent Events

11 Dec 2020 Results published in the Advances in Therapy
15 Apr 2016 Status changed from recruiting to completed.
18 Mar 2016 Planned End Date changed from 1 Mar 2016 to 1 Apr 2016 as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com